Zobrazeno 1 - 10
of 12
pro vyhledávání: '"C Y, Ponsioen"'
Autor:
M. D. Slooter, K. Talboom, S. Sharabiany, C. P. M. van Helsdingen, S. van Dieren, C. Y. Ponsioen, C. Y. Nio, E. C. J. Consten, J. H. Wijsman, M. A. Boermeester, J. P. M. Derikx, G. D. Musters, W. A. Bemelman, P. J. Tanis, R. Hompes, on behalf of the IMARI-study group
Publikováno v:
BMC Surgery, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Anastomotic leakage (AL) is still a common and feared complication after low anterior resection (LAR) for rectal cancer. The multifactorial pathophysiology of AL and lack of standardised treatment options requires a multi-modal ap
Externí odkaz:
https://doaj.org/article/f3cadfb1772b411982d0b51de6421f86
Autor:
K. Talboom, N. G. Greijdanus, N. Brinkman, R. D. Blok, S. X. Roodbeen, C. Y. Ponsioen, P. J. Tanis, W. A. Bemelman, C. Cunningham, F. B. de Lacy, Roel Hompes
Publikováno v:
Techniques in coloproctology. Springer-Verlag Italia
Purpose Comparative studies on efficacy of treatment strategies for anastomotic leakage (AL) after low anterior resection (LAR) are almost non-existent. This study aimed to compare different proactive and conservative treatment approaches for AL afte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d16365a7b97e9c8d56864c7c4956a0d
https://pure.amc.nl/en/publications/comparison-of-proactive-and-conventional-treatment-of-anastomotic-leakage-in-rectal-cancer-surgery(337dd79f-3f48-48de-bf5d-a8edd9f19ad5).html
https://pure.amc.nl/en/publications/comparison-of-proactive-and-conventional-treatment-of-anastomotic-leakage-in-rectal-cancer-surgery(337dd79f-3f48-48de-bf5d-a8edd9f19ad5).html
Autor:
T Straatmijer, M Visschedijk, A de Vries, F Hoentjen, A A van Bodegraven, A G L Bodelier, N K H de Boer, G Dijkstra, E A M Festen, C Horjus, J M Jansen, B Jharap, W Mares, B Oldenburg, C Y Ponsioen, T E H Romkens, N Srivastava, M M van der Voorn, R L West, J C van der Woude, M D J Wolvers, M Pierik, A E van der Meulen, M Duijvestein
Publikováno v:
Journal of Crohn's and Colitis. 16:i118-i120
Background Clinicians face difficulty in positioning biologics and JAK inhibitors in anti-TNF refractory ulcerative colitis (UC) patients. Head-to-head trials comparing the efficacy of vedolizumab and tofacitinib in UC patients are lacking. We aimed
Autor:
M. D. Slooter, Talboom, K., S. Sharabiany, C. P. M. Van Helsdingen, S. Van Dieren, C. Y. Ponsioen, C. Y. Nio, E. C. J. Consten, J. H. Wijsman, M. A. Boermeester, J. P. M. Derikx, G. D. Musters, W. A. Bemelman, P. J. Tanis, R. Hompes
Additional file 1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::523eaaf359632f91050fb43e97297845
Publikováno v:
The Netherlands journal of medicine. 75(10)
Real-life patterns of anti-tumour necrosis factor (anti-TNF) use remain largely unknown. We aimed to investigate survival rates, clinical outcomes and costs of anti-TNF agents in a large population of patients with inflammatory bowel disease (IBD).He
Autor:
E K K, Henriksen, M K, Viken, M, Wittig, K, Holm, T, Folseraas, S, Mucha, E, Melum, J R, Hov, K N, Lazaridis, B D, Juran, O, Chazouillères, M, Färkkilä, D N, Gotthardt, P, Invernizzi, M, Carbone, G M, Hirschfield, S M, Rushbrook, E, Goode, C Y, Ponsioen, R K, Weersma, B, Eksteen, K K, Yimam, S C, Gordon, D, Goldberg, L, Yu, C L, Bowlus, A, Franke, B A, Lie, T H, Karlsen
Publikováno v:
HLA, 90(4), 228-233. Wiley-Blackwell
HLA, 90(4), 228-233. Wiley
HLA
HLA, 90(4), 228-233. Wiley
HLA
Primary sclerosing cholangitis (PSC) is strongly associated with several human leukocyte antigen (HLA) haplotypes. Due to extensive linkage disequilibrium and multiple polymorphic candidate genes in the HLA complex, identifying the alleles responsibl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d097f848955a532f2f2f76288454a470
https://pure.amc.nl/en/publications/hla-haplotypes-in-primary-sclerosing-cholangitis-patients-of-admixed-and-noneuropean-ancestry(58bba8e0-5bf7-4583-b32f-10090ddcb41c).html
https://pure.amc.nl/en/publications/hla-haplotypes-in-primary-sclerosing-cholangitis-patients-of-admixed-and-noneuropean-ancestry(58bba8e0-5bf7-4583-b32f-10090ddcb41c).html
Autor:
J M, Dumonceau, A, Riphaus, J R, Aparicio, U, Beilenhoff, J T A, Knape, M, Ortmann, G, Paspatis, C Y, Ponsioen, I, Racz, F, Schreiber, P, Vilmann, T, Wehrmann, C, Wientjes, B, Walder, M, Dinis-Ribeiro
Publikováno v:
European journal of anaesthesiology, 27(12), 1016-1030. Wolters Kluwer Health
Endoscopy, Vol. 42, No 11 (2010) pp. 960-974
Endoscopy, 42(11), 960-974. Georg Thieme Verlag
Endoscopy, Vol. 42, No 11 (2010) pp. 960-974
Endoscopy, 42(11), 960-974. Georg Thieme Verlag
Propofol sedation by non-anaesthesiologists is an upcoming sedation regimen in several countries throughout Europe. Numerous studies have shown the efficacy and safety of this sedation regimen in gastrointestinal endoscopy. Nevertheless, this issue r
Autor:
B W M, Spanier, E M H, Mathus-Vliegen, H A R E, Tuynman, R W M, Van der Hulst, M G W, Dijkgraaf, M J, Bruno, C Y, Ponsioen
Publikováno v:
Alimentary pharmacology & therapeutics, 28(9), 1159-1165. Wiley-Blackwell
Summary Background Following a nil per os (NPO) regimen, most patients with acute pancreatitis (AP) can resume normal oral intake within 1 week. If not tolerated, it is recommended to initiate artificial feeding, preferably by the enteral route. Aim
Autor:
E Festen, Andrea E. van der Meulen-de Jong, C. Y. Ponsioen, F. Hoentjen, Marie J. Pierik, Lieke M. Spekhorst, M Lowenberg, Dirk J. de Jong, Rinse K. Weersma, Gerard Dijkstra, M. Severs, N. K. H. de Boer, Bas Oldenburg, Floris Imhann, H. H. Fidder, C.J. van der Woude
Publikováno v:
Journal of Crohn's and Colitis. 11:S28-S28
Publikováno v:
Abdominal imaging, 26(1), 43-47. Springer New York
BACKGROUND: There is no uniformly accepted classification system for the range of cholangiographic abnormalities encountered in primary sclerosing cholangitis (PSC). The aims of this study were to evaluate a previously developed classification system